WO2005015204A3 - Diagnostics and therapeutics for diseases associated with organic anion transporter ust3 like 3 (ust3 like 3) - Google Patents

Diagnostics and therapeutics for diseases associated with organic anion transporter ust3 like 3 (ust3 like 3) Download PDF

Info

Publication number
WO2005015204A3
WO2005015204A3 PCT/EP2004/008345 EP2004008345W WO2005015204A3 WO 2005015204 A3 WO2005015204 A3 WO 2005015204A3 EP 2004008345 W EP2004008345 W EP 2004008345W WO 2005015204 A3 WO2005015204 A3 WO 2005015204A3
Authority
WO
WIPO (PCT)
Prior art keywords
ust3
disorders
therapeutics
diagnostics
diseases associated
Prior art date
Application number
PCT/EP2004/008345
Other languages
French (fr)
Other versions
WO2005015204A2 (en
Inventor
Stefan Golz
Ulf Brueggemeier
Andreas Geerts
Original Assignee
Bayer Healthcare Ag
Stefan Golz
Ulf Brueggemeier
Andreas Geerts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag, Stefan Golz, Ulf Brueggemeier, Andreas Geerts filed Critical Bayer Healthcare Ag
Publication of WO2005015204A2 publication Critical patent/WO2005015204A2/en
Publication of WO2005015204A3 publication Critical patent/WO2005015204A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention provides a human UST3 like 3 which is associated with the neurological disorders, cardiovascular disorders, urological disorders, metabolic diseases, cancer, developmental disorders and gastroenterological disorders. The invention also provides assays for the identification of compounds useful in the treatment or prevention of neurological disorders, cardiovascular disorders, urological disorders, metabolic diseases, cancer, developmental disorders and gastroenterological disorders. The invention also features compounds which bind to and/or activate or inhibit the activity of UST3 like 3 as well as pharmaceutical compositions comprising such compounds.
PCT/EP2004/008345 2003-08-06 2004-07-26 Diagnostics and therapeutics for diseases associated with organic anion transporter ust3 like 3 (ust3 like 3) WO2005015204A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03017529 2003-08-06
EP03017529.3 2003-08-06

Publications (2)

Publication Number Publication Date
WO2005015204A2 WO2005015204A2 (en) 2005-02-17
WO2005015204A3 true WO2005015204A3 (en) 2005-04-07

Family

ID=34130048

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2004/008345 WO2005015204A2 (en) 2003-08-06 2004-07-26 Diagnostics and therapeutics for diseases associated with organic anion transporter ust3 like 3 (ust3 like 3)

Country Status (1)

Country Link
WO (1) WO2005015204A2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002046415A2 (en) * 2000-12-08 2002-06-13 Incyte Genomics, Inc. Polynucleotide and polypeptide sequences of putative transporters and ion channells

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002046415A2 (en) * 2000-12-08 2002-06-13 Incyte Genomics, Inc. Polynucleotide and polypeptide sequences of putative transporters and ion channells

Also Published As

Publication number Publication date
WO2005015204A2 (en) 2005-02-17

Similar Documents

Publication Publication Date Title
WO2005093092A3 (en) Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 44 (gpr44)
WO2005106012A3 (en) Diagnostics and therapeutics for diseases associated with dipeptidyl-peptidase 1 (dpp1)
WO2005040828A3 (en) Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 49 (gpr49)
WO2004080373A3 (en) Diagnostics and therapeutics for diseases associated with g-protein coupled proteinase activated receptor 2 (par2)
WO2006010514A3 (en) Diagnostics and therapeutics for diseases associated with dual specificity mitogen-activated protein kinase kinase 5 (map2k5)
WO2005022164A3 (en) Diagnostics and therapeutics for diseases associated with kallikrein 8 (klk8)
WO2005093091A3 (en) Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 26 (gpr26)
WO2005015204A3 (en) Diagnostics and therapeutics for diseases associated with organic anion transporter ust3 like 3 (ust3 like 3)
WO2005026724A3 (en) Diagnostics and therapeutics for diseases associated with organic cation transporter slc22a5 (slc22a5)
WO2005040825A3 (en) Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 20 (gpr20)
WO2005026736A3 (en) Diagnostics and therapeutics for diseases associated with organic cation transporter slc22a2 (slc22a2)
WO2005026738A3 (en) Diagnostics and therapeutics for diseases associated with organic cation transporter slc22a9 (slc22a9)
WO2004081563A3 (en) Diagnostics and therapeutics for diseases associated with phosphodiesterase 1a (pde1a)
WO2004080374A3 (en) Diagnostics and therapeutics for diseases associated with phosphodi-esterase 1c (pde1c)
WO2005029086A3 (en) Diagnostics and therapeutics for diseases associated with organic cation transporter slc22a10 (ust3-like2) (slc22a10)
WO2005026719A3 (en) Diagnostics and therapeutics for diseases associated with transporter slc22a3 (slc22a3)
WO2005040790A3 (en) Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 75 (gpr75)
WO2005026737A3 (en) Diagnostics and therapeutics for diseases associated with organic cation transporter slc22a4 (slc22a4)
WO2004099248A3 (en) Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor agtr2 (agtr2)
WO2004082571A3 (en) Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 86 (gpr86)
WO2006013012A3 (en) Diagnostics and therapeutics for diseases associated with napsin 1 (nap1)
WO2004106934A3 (en) Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7)
WO2005029085A3 (en) Diagnostics and therapeutics for diseases associated with organic cation transporter slc22a11 (slc22a11)
WO2005040818A3 (en) Diagnostics and therapeutics for diseases associated with organic cation transporter flipt1 (flipt1)
WO2005100997A3 (en) Diagnostics and therapeutics for diseases associated with tachykinin receptor 3 (tacr3)

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase